Compare Cassava Sciences Inc (FLNA) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Realty Income Corp — how do they compare? Cassava Sciences Inc trades at $1.06 (market cap $53.14M), while Realty Income Corp trades at $65.44 (market cap $58.99B). The key difference: Realty Income Corp is far larger — about 1110.1× Cassava Sciences Inc's market cap, and Realty Income Corp pays a 5.14% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | O | |
|---|---|---|
Market Cap | $53.14M | $58.99B |
Sector | Health | Real Estate |
52-Week High | $4.64 | $67.56 |
52-Week Low | $1.09 | $55.93 |
Enterprise Value | -$33.43M | $88.79B |
Dividend Yield | — | 5.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
Realty Income (O) trades at $65.04, up 1.99% on the day, near its consensus price target of $67.50. The stock shows bullish technical signals with strong moving averages and support at $63. Recent earnings have missed expectations for three consecutive quarters, though revenue grew to $5.75B in 2025. The company maintains a high gross margin of 92.54% and recently expanded its credit facilities to $5.5B, supporting growth initiatives.
Outlook remains cautiously optimistic with 41% analyst buy ratings, but elevated P/E of 51.85 and consistent earnings misses pose valuation risks. Dividend stability and liquidity improvements provide income investor appeal, yet debt levels rising to 39.93% of assets require monitoring. The stock offers steady income but faces pressure to meet earnings forecasts for sustained upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
